Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01217827 · ClinicalTrials.gov registry record · Phase 3
Implantable Cardioverter-Defibrillator Use in the VA System
A Phase 3 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 89
- Enrollment target
NCT01217827: Completed Phase 3 study, sponsored by Stanford University.
NCT01217827 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01217827, a Phase 3 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 89 participants
- Enrollment target
Study Summary
Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon prior research, a major barrier to low utilization is low referral of potential candidates by healthcare providers. In this study, via brief clinical reminder placed in the electronic medical record, we ask healthcare providers who have not referred potential candidates for defibrillator the reasons for this decision and provide them with the tools for referral if appropriate.
Interventions
- BEHAVIORAL Clinical Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2010-04 |
| Est. Completion | 2013-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01217827
The ClinicalTrials.gov registry entry for NCT01217827 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Reminder is the first listed.
NCT01217827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01217827 about?
NCT01217827 is a clinical study titled "Implantable Cardioverter-Defibrillator Use in the VA System". Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon prior research, a major barrier to low utilization is low referral of potential candidates by healthc...
What is the current status of trial NCT01217827?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 89 participants. The study started on 2010-04. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01217827?
The interventions under investigation include: Clinical Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT01217827?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.